Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive prescription drugs, these programs such as a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely lower permeability to oxyge